A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
To assess efficacy, and safety of a single sustained release dose of the OTX-TIC drug product (2 travoprost dose strengths) in subjects with Open Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Epistemonikos ID: c550c3b460c4b11de6c5749d464a525ef2cc132f
First added on: May 13, 2024